Skip to content

News Articles

Latest articles, insights, and updates from the blog.

126 articles

Contact Ketamine Tablet

Send corrections, provider questions, or advertising inquiries.

Study Revisits Ketamine and Opioid Receptors Link visual guide
LatestNews

Study Revisits Ketamine and Opioid Receptors Link

A newly reported ketamine opioid-receptor study raises useful safety, dosing, and care-planning questions for oral ketamine patients.

1 min read
Read article
News1 min read

Ketamine's Neuroplasticity Boost Isn't Universal

New research reported by Medical News Bulletin finds ketamine's neuroplasticity boost varies by person, here's what it means for oral tablet dosing.

News1 min read

Better U Expands At-Home Ketamine Eligibility Info for 2026

Better U says it has expanded 2026 patient eligibility and safety guidance for at-home ketamine therapy. Here's what oral ketamine users should know.

News1 min read

Treatment-Resistant Depression: Oral Ketamine's Role

STAT examines what comes next when oral antidepressants fail. Here's how oral ketamine tablets fit into the treatment-resistant depression conversation.

News1 min read

Lilly's $2.8B AtaiBeckley Deal Signals Pharma Shift

Eli Lilly's $2.8B acquisition of AtaiBeckley marks a major Big Pharma push into psychedelic medicine. What ketamine tablet patients should watch now.

News1 min read

VA Ketamine Therapy Cuts Threaten Veterans' Relief

Veterans relying on ketamine programs for PTSD relief face uncertainty as funding cuts loom. Here's what oral ketamine tablets mean for access.

News1 min read

Wisconsin Man's Depression Story: What Oral Ketamine Offers

A Wisconsin man's ketamine treatment success raises awareness of oral tablet options for depression. What patients should know before starting.

News1 min read

Study: Ketamine Relieves Treatment-Resistant Depression

New research highlights ketamine's potential against resistant depression and suicidal thoughts. Here's what tablet users need to know about access and dosing.

News1 min read

NRx Pharma Gets FDA Expanded Access for Ketamine Protocol

NRx Pharmaceuticals received an FDA Expanded Access grant for its ketamine-bridging treatment program. Here's what it means for patients and oral ketamine access.

News1 min read

Brain Scans Could Predict Ketamine Tablet Success

New research shows brain imaging may predict which depression patients will respond to ketamine tablets before treatment begins.

News1 min read

Expert Highlights Key Patient Considerations for Ketamine

Dr. Benjamin Brody shares crucial patient safety and treatment considerations for ketamine therapy at major psychiatric conference.

News1 min read

Boston Clinics Spotlight Ketamine's Mental Health Role

Boston health clinics are expanding ketamine therapy for depression and PTSD — here's what it means for patients exploring oral ketamine tablets.

News1 min read

One Patient's Year With Ketamine and Experimental Care

A Guardian journalist tried ketamine and other cutting-edge depression treatments for a year. What oral ketamine patients can learn from her experience.